Schedule 13D ownership disclosure

RENEO PHARMACEUTICALS INC

Security class unavailable · CUSIP: 75974E103

Event date: 2023-05-08

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
0.9700%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-23-156675
Form type
SC 13D/A
Filer
OnKure Therapeutics, Inc.
CIK
CIK 1637715
Filed
May 30, 2023
Reporting period
May 08, 2023
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub